Rafael Holdings RFL
NYSE RFL
$1.10 +0.02 (+2.34%)
As of: Nov 11, 2026 · 3:59 PM EST

Rafael Holdings (RFL) Asset Writedowns and Impairment (2020 - 2025)

Updated

Analysis

Rafael Holdings (RFL) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rafael Holdings 55.50 Mn -74.75 Mn 218,000.00
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 3.05 Mn
Jul 31, 2023 -17,000.00
Apr 30, 2023 128,000.00
Jan 31, 2023 67,000.00
Oct 31, 2022 156,000.00
Oct 31, 2020 724,000.00
Jul 31, 2020 3.71 Mn
Apr 30, 2020 295,000.00
API Access

Rafael Holdings Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RFL&period=max&api_key=YOUR_API_KEY